Lamond David

Average Profitability
<0.0001%
Insider Buys Quantity
14
Insider Buys Sum
$601,547.46
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Lamond David

According to the SEC Form 4 filings, Lamond David, being in a position of

  1. director at Quince Therapeutics, Inc.,
    оver the last 12 months, has bought 168384 shares for $167,913, and sold 0 shares,
    over all time since 2023-08-15, has bought 500436 shares for $601,547, and sold 0 shares.

The largest purchase of all time was on 2023-08-16 and amounted to 117348 shares of Quince Therapeutics, Inc. for $151,379.

Biography of Lamond David

No biography is available at this moment.

2023-12-14PurchaseQuince Therapeutics, Inc.
QNCX
director
22,627
0.0528%
$1.04$23,532-3.37%
2023-12-13PurchaseQuince Therapeutics, Inc.
QNCX
director
22,627
0.0528%
$1.00$22,627+1.03%
2023-12-12PurchaseQuince Therapeutics, Inc.
QNCX
director
22,627
0.0544%
$1.02$23,074+0.5%
2023-12-07PurchaseQuince Therapeutics, Inc.
QNCX
director
19,123
0.0446%
$1.01$19,314-0.99%
2023-12-06PurchaseQuince Therapeutics, Inc.
QNCX
director
19,123
0.0455%
$1.02$19,5050%
2023-12-05PurchaseQuince Therapeutics, Inc.
QNCX
director
19,123
0.0466%
$1.01$19,314+1.83%
2023-12-01PurchaseQuince Therapeutics, Inc.
QNCX
director
14,378
0.033%
$0.94$13,515+4.87%
2023-11-30PurchaseQuince Therapeutics, Inc.
QNCX
director
14,378
0.035%
$0.90$12,940+15.99%
2023-11-29PurchaseQuince Therapeutics, Inc.
QNCX
director
14,378
0.035%
$0.98$14,090+6.34%
2023-08-31PurchaseQuince Therapeutics, Inc.
QNCX
director
41,026
0.1136%
$1.32$54,154-21.37%
2023-08-30PurchaseQuince Therapeutics, Inc.
QNCX
director
41,026
0.1145%
$1.31$53,744-19.77%
2023-08-17PurchaseQuince Therapeutics, Inc.
QNCX
director
24,766
0.0684%
$1.29$31,948-17.32%
2023-08-16PurchaseQuince Therapeutics, Inc.
QNCX
director
117,348
0.323%
$1.29$151,379-18.22%
2023-08-15PurchaseQuince Therapeutics, Inc.
QNCX
director
107,886
0.3087%
$1.32$142,410-16.54%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.